We aim to enable effective T cell targeting of solid cancers by co-engineering T cells with tumour-antigen specific CARs and for local release of an antagonist that selectively depletes immunosuppressive myeloid cell populations in tumour tissues. Our multimodal cellular targeting and imaging strategy will include in vivo tracking of the inflammatory tumour microenvironment, the fate of the CAR T cells and released antagonist along with local tumour growth and dissemination. The insights from this project will inform clinical translation of this novel strategy.
Rössig, Claudia | Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie - (UKM PHO) |
Rössig, Claudia | Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie - (UKM PHO) |